PMC:7600245 / 32956-33998
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T129 | 190-195 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T130 | 401-413 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T131 | 575-580 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T120 | 74-82 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T121 | 85-94 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T122 | 168-176 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T123 | 345-353 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T124 | 516-524 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T125 | 720-728 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T298 | 182-195 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T299 | 499-507 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T300 | 568-574 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco-2 |
T301 | 568-574 | http://purl.obolibrary.org/obo/CLO_0051943 | denotes | Caco-2 |
T302 | 568-574 | http://purl.obolibrary.org/obo/CLO_0051958 | denotes | Caco-2 |
T303 | 568-574 | http://purl.obolibrary.org/obo/CLO_0051960 | denotes | Caco-2 |
T304 | 575-580 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T305 | 618-619 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T491 | 0-9 | Chemical | denotes | Darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T492 | 10-20 | Chemical | denotes | cobicistat | http://purl.obolibrary.org/obo/CHEBI_72291 |
T493 | 130-139 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T494 | 291-300 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T495 | 401-413 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T496 | 462-471 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T497 | 472-482 | Chemical | denotes | cobicistat | http://purl.obolibrary.org/obo/CHEBI_72291 |
T498 | 669-678 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T499 | 679-689 | Chemical | denotes | cobicistat | http://purl.obolibrary.org/obo/CHEBI_72291 |
T500 | 757-766 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T501 | 824-834 | Chemical | denotes | cobicistat | http://purl.obolibrary.org/obo/CHEBI_72291 |
T502 | 858-867 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T503 | 868-886 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T504 | 910-919 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T505 | 920-931 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T506 | 933-942 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T507 | 943-954 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T508 | 955-973 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T509 | 978-987 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T510 | 988-999 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T511 | 1000-1018 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T240 | 0-95 | Sentence | denotes | Darunavir/cobicistat is under clinical investigation for the treatment of SARS-CoV-2 infection. |
T241 | 96-251 | Sentence | denotes | This is potentially attributed to darunavir ability to in vitro inhibit SARS-CoV-2 in Vero E6 cells, albeit at high concentrations (EC50 = 46.41 µM) [104]. |
T242 | 252-356 | Sentence | denotes | Mechanistically, this could be because darunavir potentially inhibits 3CLpro and/or PLpro of SARS-CoV-2. |
T243 | 357-425 | Sentence | denotes | The two enzymes are important for the viral glycoprotein processing. |
T244 | 426-587 | Sentence | denotes | However, in another in vitro study, darunavir/cobicistat demonstrated no activity against SARS-CoV-2 at clinically relevant concentrations in Caco-2 cells [105]. |
T245 | 588-744 | Sentence | denotes | Furthermore, the results from a randomized controlled trial in China showed that darunavir/cobicistat was not effective in treating COVID-19 patients [106]. |
T246 | 745-1042 | Sentence | denotes | Regardless, darunavir is being tried in about three trials in combination with cobicistat (NCT04252274; n = 30), ritonavir/hydroxychloroquine (NCT04435587; n = 80), ritonavir/oseltamivir, ritonavir/oseltamivir/hydroxychloroquine, or ritonavir/favipiravir/hydroxychloroquine (NCT04303299; n = 320). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
965 | 336-341 | Gene | denotes | PLpro | Gene:43740578 |
966 | 168-178 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
967 | 345-355 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
968 | 516-526 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
969 | 729-737 | Species | denotes | patients | Tax:9606 |
970 | 0-20 | Chemical | denotes | Darunavir/cobicistat | |
971 | 130-139 | Chemical | denotes | darunavir | MESH:D000069454 |
972 | 291-300 | Chemical | denotes | darunavir | MESH:D000069454 |
973 | 462-472 | Chemical | denotes | darunavir/ | MESH:D000069454 |
974 | 472-482 | Chemical | denotes | cobicistat | MESH:D000069547 |
975 | 669-689 | Chemical | denotes | darunavir/cobicistat | |
976 | 757-766 | Chemical | denotes | darunavir | MESH:D000069454 |
977 | 824-834 | Chemical | denotes | cobicistat | MESH:D000069547 |
978 | 858-886 | Chemical | denotes | ritonavir/hydroxychloroquine | |
979 | 910-931 | Chemical | denotes | ritonavir/oseltamivir | |
980 | 933-942 | Chemical | denotes | ritonavir | MESH:D019438 |
981 | 943-954 | Chemical | denotes | oseltamivir | MESH:D053139 |
982 | 955-973 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
983 | 978-1018 | Chemical | denotes | ritonavir/favipiravir/hydroxychloroquine | |
984 | 74-94 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
985 | 720-728 | Disease | denotes | COVID-19 | MESH:C000657245 |
986 | 187-189 | CellLine | denotes | E6 | CVCL:4582 |
987 | 568-574 | CellLine | denotes | Caco-2 | CVCL:0025 |